These data are supported by the fact that, in the 4T1-BALB/c BC allograft mouse model, the inhibition of TGF-β causes a significant reduction in the levels of CCL2 expression in the primary tumor site, which correlates with lower levels of lung metastases14. Here, CCL2 is linked to neoplasm.